D.L. Carlson Investment Group’s Alexion Pharmaceuticals ALXN Stock Holding History

D.L. Carlson Investment Group’s Portfolio ALXN Stock Details ALXN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q2	–	Sell	-11,137	Closed	-$1.55M	–	136
2016 Q1	$1.55M	Sell	11,137 -150	-1%	-$22K	0.58%	70
2015 Q4	$2.15M	Sell	11,287 -465	-4%	-$81.2K	0.8%	55
2015 Q3	$1.84M	Sell	11,752 -2,370	-17%	-$432K	0.74%	59
2015 Q2	$2.55M	Sell	14,122 -3	-0%	-$518	0.92%	40
2015 Q1	$2.45M	Sell	14,125 -1,930	-12%	-$349K	0.87%	49
2014 Q4	$2.97M	Buy	16,055 +5,500	+52%	+$1.02M	1.07%	37
2014 Q3	$1.75M	Buy	+10,555	New	+$1.73M	0.65%	65

Other funds holding ALXN

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

D.L. Carlson Investment Group's ALXN Position: Q2 2016 in Review

D.L. Carlson Investment Group sold out of Alexion Pharmaceuticals (ALXN) in Q2 2016, closing a stake of 11,137 shares — an estimated $1.55M sold.

D.L. Carlson Investment Group first reported a position in ALXN in Q3 2014 and held it in 7 quarters. The position peaked at $2.97M in Q4 2014. 533 funds tracked by Wall St. Rank hold ALXN as of Q2 2016.

D.L. Carlson Investment Group reported no remaining Alexion Pharmaceuticals position as of Q2 2016 after selling out during the quarter.
D.L. Carlson Investment Group sold 11,137 Alexion Pharmaceuticals shares in Q2 2016, an estimated $1.55M.
D.L. Carlson Investment Group first reported a position in Alexion Pharmaceuticals in Q3 2014 and held it in 7 quarters.
D.L. Carlson Investment Group's Alexion Pharmaceuticals position peaked at $2.97M in Q4 2014.
533 funds tracked by Wall St. Rank held Alexion Pharmaceuticals as of Q2 2016.

Based on D.L. Carlson Investment Group's 13F filing for Q2 2016, filed 10 Aug 2016.